Protective cellular immune responses in HIV-1 discordant couples
HIV-1 不一致夫妇的保护性细胞免疫反应
基本信息
- 批准号:7678364
- 负责人:
- 金额:$ 62.05万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAntigenic SpecificityBiological AssayCD4 Positive T LymphocytesCD8B1 geneCell physiologyCellular ImmunityCohort StudiesCommunitiesConsensus SequenceCounselingCouplesDataDevelopmentEnrollmentEpidemiologic StudiesEpitopesEventEvolutionExposure toFutureGeneticGenital systemGenomeHIVHIV SeropositivityHIV-1HeterosexualsHumanImmune responseImmunityImmunologicsImmunology procedureIndividualInfantInfectionInterferon Type IIKenyaLaboratoriesLiteratureMeasuresMonitorMothersNaturePeptidesPhenotypePlasmaPlayPredispositionPrevalencePreventionProcessProspective StudiesRNARecruitment ActivityReportingResearch DesignResearch PersonnelRiskRoleSex BehaviorSiteSpecificitySpecimenStaining methodStainsSystemT-LymphocyteTestingTimeVaccine ResearchViralViral Load resultViral MarkersVirusVisitbasecohortcytokinedesignexperiencefollow-upgenital secretioninsightinterestmemberpeptide Apreventprogramsprospectiveprotective effectresistance mechanismresponsesex risktransmission processvaccine development
项目摘要
DESCRIPTION (provided by applicant): Approximately 1 out of 10 couples in Kenya is HIV-1 discordant despite ongoing sexual activity that results in HIV-1 exposure for the uninfected member of the couple. Several groups have described cellular immune responses in HIV-1-exposed individuals and have suggested that these contribute to reduced susceptibility to HIV-1 infection. However, none of these studies has been able to determine whether the presence of an HIV-1-specific immune response protects against HIV-1 acquisition or is merely a marker of intermittent viral exposure. In this study, we propose to recruit a large cohort of HIV-1-discordant couples and follow both members of the couple prospectively, using HIV-1 transmission as the endpoint. For Aim 1 we will determine whether positive HIV-1-specific CD8+ interferon-gamma (IFN-gamma) responses in the HIV-1-uninfected partner are associated with protection against HIV-1 acquisition during 24 months of follow-up. Aim 2 focuses on HIV-1- specific CD4+ T helper responses and will ascertain whether these are significantly more common in non- transmitting couples compared to HIV-1 transmitting couples. In Aim 3 we will perform detailed analyses of HIV-1-specific T cell function, phenotype, and durability in a subset of 10 enrolled couples, defining viral specificity by sequencing genital and plasma HIV-1 from infected partners. A total of 600 HIV-1-discordant couples will be enrolled in this Nairobi-based study, with approximately 1/3 of couples recruited from an ongoing discordant couple study and the remaining coming from the community. At enrollment, CD8+ and CD4+ T cell responses against peptides derived from a consensus sequence clade A HIV-1 will be measured in the uninfected partner using ELISpot assays and intracellular cytokine staining. At the same visit, HIV-1-infected partners will have a baseline HIV-1 viral load and genital tract HIV-1 RNA shedding quantified using PCR. Follow-up visits will occur every 3 months for both partners and will include assessment of sexual risk behavior and rapid HIV-1 testing for the uninfected partner. During 2 years of follow-up, we estimate 54-65 (approximately 10%) couples will transmit HIV-1 despite regular HIV-1 prevention counseling. Comparing HIV-1 transmitting with non-transmitting couples will inform future vaccine research about whether such responses are associated with reductions in HIV-1 acquisition and may provide valuable insight into the nature of protective cellular immunity for future vaccine development.
描述(由申请人提供):肯尼亚的10对夫妇中约有1名是HIV-1不一致的,尽管持续的性活动会导致这对夫妇未感染的成员HIV-1暴露。几个组描述了暴露于HIV-1的个体中的细胞免疫反应,并提出这些反应有助于降低对HIV-1感染的敏感性。但是,这些研究都无法确定HIV-1特异性免疫反应的存在是否可以防止HIV-1的获取或仅仅是间歇性病毒暴露的标志。在这项研究中,我们建议招募一大批HIV-1五杆夫妇,并以HIV-1传播为终点,并前瞻性地跟随这对夫妇的两个成员。对于AIM 1,我们将确定HIV-1未感染的伴侣中HIV-1特异性CD8+干扰素 - γ(IFN-GAMMA)反应是否与在随访的24个月内的保护HIV-1获取有关。 AIM 2专注于HIV-1-特异性CD4+ T助手响应,并将确定与HIV-1传播夫妇相比,在非传播夫妇中是否明显更为普遍。在AIM 3中,我们将对10对夫妇的子集进行HIV-1特异性T细胞功能,表型和耐用性的详细分析,从而通过对受感染伴侣进行测序生殖器和血浆HIV-1来定义病毒特异性。这项基于内罗毕的研究将总共参加600对HIV-1五夫妻夫妇,大约有1/3对来自正在进行的不一致的夫妇研究中招募的夫妇,其余的来自社区。在入学时,使用ELISPOT分析和细胞内细胞因子染色,将在未感染的伴侣中测量源自共有序列进化枝A HIV-1的肽的CD8+和CD4+ T细胞反应。在同一访问中,HIV-1感染的伴侣将具有基线HIV-1病毒载量和使用PCR定量的生殖道HIV-1 RNA脱落。双方伴侣将每3个月进行一次随访,并包括对未感染伴侣进行性风险行为的评估和快速的HIV-1测试。在2年的随访期间,我们估计尽管有常规的HIV-1预防咨询,夫妻将传递HIV-1(约10%)。将HIV-1传输与非推广夫妇进行比较,将为未来的疫苗研究提供有关此类反应是否与HIV-1获取的减少相关的疫苗研究,并可能对保护性细胞免疫的性质有价值,以实现未来的疫苗开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAREY FARQUHAR其他文献
CAREY FARQUHAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAREY FARQUHAR', 18)}}的其他基金
Subclinical cardiac dysfunction after hypertensive disorders in pregnancy
妊娠期高血压疾病后的亚临床心功能不全
- 批准号:
10002116 - 财政年份:2019
- 资助金额:
$ 62.05万 - 项目类别:
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
整合辅助合作伙伴服务和系统发育学以预防 HIV 和 HCV
- 批准号:
10208545 - 财政年份:2017
- 资助金额:
$ 62.05万 - 项目类别:
IMPLEMENTING ASSISTED PARTNER SERVICES TO HIV TEST AND TREAT MEN IN WESTERN KENYA
为肯尼亚西部的男性实施艾滋病毒检测和治疗的辅助合作伙伴服务
- 批准号:
9797235 - 财政年份:2017
- 资助金额:
$ 62.05万 - 项目类别:
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
整合辅助合作伙伴服务和系统发育学以预防 HIV 和 HCV
- 批准号:
10086117 - 财政年份:2017
- 资助金额:
$ 62.05万 - 项目类别:
Implementing Assisted Partner Services to HIV Test and Treat Men in Western Kenya
在肯尼亚西部实施艾滋病毒检测和治疗男性辅助合作伙伴服务
- 批准号:
9407079 - 财政年份:2017
- 资助金额:
$ 62.05万 - 项目类别:
Implementing Assisted Partner Services to HIV Test and Treat Men in Western Kenya
在肯尼亚西部实施艾滋病毒检测和治疗男性辅助合作伙伴服务
- 批准号:
10155081 - 财政年份:2017
- 资助金额:
$ 62.05万 - 项目类别:
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults
预测感染艾滋病毒和未感染艾滋病毒的肯尼亚成年人的早期心血管风险
- 批准号:
9354370 - 财政年份:2016
- 资助金额:
$ 62.05万 - 项目类别:
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults
预测感染艾滋病毒和未感染艾滋病毒的肯尼亚成年人的早期心血管风险
- 批准号:
9231919 - 财政年份:2016
- 资助金额:
$ 62.05万 - 项目类别:
Women and HIV: Translation of Research into Practice
妇女与艾滋病毒:研究转化为实践
- 批准号:
9283645 - 财政年份:2015
- 资助金额:
$ 62.05万 - 项目类别:
Women and HIV: Translation of Research into Practice
妇女与艾滋病毒:研究转化为实践
- 批准号:
9488546 - 财政年份:2015
- 资助金额:
$ 62.05万 - 项目类别:
相似国自然基金
不同疫苗诱导抗原特异性长寿浆细胞形成的机制研究
- 批准号:32370942
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
牙鲆腹腔源MHCII和CD80/86阳性外泌体对抗原特异性免疫应答调控机制的研究
- 批准号:32373160
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新功能型乳酸菌诱导肠道抗原特异性IgA+B细胞经“肠-肺轴”迁移的分子免疫机制研究
- 批准号:32373023
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于抗原特异性识别原理的巨细胞病毒特异性T细胞转换器设计及抗肿瘤机制研究
- 批准号:82304361
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Point-of-care diagnostic test for T. cruzi (Chagas) infection
克氏锥虫(恰加斯)感染的即时诊断测试
- 批准号:
10603665 - 财政年份:2023
- 资助金额:
$ 62.05万 - 项目类别:
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
通过细胞间酶标记定义 T 细胞在生发中心的作用
- 批准号:
10566601 - 财政年份:2022
- 资助金额:
$ 62.05万 - 项目类别:
Development of a highly-sensitive urine test for tuberculosis (TB) that detects diverse forms of urinary TB lipoarabinomannan (uLAM)
开发一种高灵敏度的结核病尿液检测方法,可检测多种形式的尿液结核菌脂阿拉伯甘露聚糖 (uLAM)
- 批准号:
10667871 - 财政年份:2022
- 资助金额:
$ 62.05万 - 项目类别:
Rational design and efficacy testing of vaccines against HCV
HCV疫苗的合理设计和功效测试
- 批准号:
10618256 - 财政年份:2022
- 资助金额:
$ 62.05万 - 项目类别:
Evaluating Efficacy of Antiseptic Mouth Rinses on Salivary SARS-CoV-2 Infectivity
评估抗菌漱口水对唾液 SARS-CoV-2 感染性的功效
- 批准号:
10354566 - 财政年份:2022
- 资助金额:
$ 62.05万 - 项目类别: